Trius Therapeutics Inc 4
4 · Trius Therapeutics Inc · Filed Jun 4, 2013
Insider Transaction Report
Form 4
Bartizal Ken
Chief Development Officer
Transactions
- Sale
Common Stock
2013-06-04$7.90/sh−2,000$15,800→ 97,300 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
- [F2]Includes 373 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/20/13.